Sanders Statement on Senate Vote on Job-Killing Trade Bill
WASHINGTON, May 21 – Sen. Bernie Sanders (I-Vt.) issued the following statement today after the Senate voted to advance a bill that would grant President Barack Obama accelerated power to complete a massive trade accord with 11 other Pacific Rim nations: “The Senate just put the interests of powerful multi-national corporations, drug companies and Wall Street ahead of the needs
After 5 Big Banks Plead Guilty to Crimes, Sanders Says Wall Street Business Model is Fraud
WASHINGTON, May 20 – Sen. Bernie Sanders (I-Vt.) issued the following statement today after five big banks agreed to pay more than $5 billion and plead guilty to crimes: “Despite weak financial regulatory systems around the world, it seems that every week we hear about another multi-billion scandal involving a major financial institution. Today, we learn that JP Morgan Chase,
Sanders Applauds LA Vote to Raise Minimum Wage
WASHINGTON, May 20 – Sen. Bernie Sanders (I-Vt.) issued the following statement today congratulating Los Angeles after the City Council in the nation’s second-largest city voted 14-1 to approve an increase in the minimum wage to $15 an hour over five years: “I congratulate the Los Angeles City Council for voting to raise the minimum wage to $15 per hour.
Sanders: Make College Tuition-Free
WASHINGTON, May 19 – Sen. Bernie Sanders (I-Vt.) today introduced legislation to make 4-year public colleges and universities tuition free. “We live in a highly competitive global economy. If our economy is to be strong, we need the best educated work force in the world. That will not happen if every year hundreds of thousands of bright young people cannot
Sanders, Cummings File Bill on Rising Rx Prices
WASHINGTON, May 18, – Sen. Bernie Sanders (I-Vt.) and Rep. Elijah E. Cummings (D-Md.) today introduced legislation to curb skyrocketing prices of generic drugs. Sharp price hikes not only impact consumers, hospitals, and pharmacists, but strain the budgets for Medicaid, Medicare, the Department of Defense and the Department of Veterans Affairs. Under current law, brand-name drug manufacturers must pay a